Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0015 | 0.0781 | 0.0781 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0022 | 0.1961 | 0.128 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.4628 | 0.4172 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.4628 | 0.4172 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0043 | 0.5538 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.4628 | 0.4628 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0022 | 0.1961 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0015 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0017 | 0.1158 | 0.0408 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0068 | 1 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0015 | 0.0781 | 0.0781 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0068 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0017 | 0.1158 | 0.0408 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0017 | 0.1158 | 0.0408 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.4628 | 0.4172 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0043 | 0.5538 | 0.516 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0068 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.4628 | 0.4628 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0011 | 0.0176 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0043 | 0.5538 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0015 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0015 | 0.0781 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Echinococcus granulosus | transcription factor Dp 1 | 0.004 | 0.5027 | 0.5027 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0032 | 0.3752 | 0.3223 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1961 | 0.128 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0068 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0037 | 0.4628 | 0.4628 |
Brugia malayi | polk-prov protein | 0.0032 | 0.3752 | 0.3752 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0068 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0043 | 0.5538 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Leishmania major | DNA polymerase kappa, putative | 0.0022 | 0.1961 | 0.128 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0015 | 0.0781 | 0.0781 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0015 | 0.0781 | 0.0781 |
Schistosoma mansoni | DNA polymerase eta | 0.0015 | 0.0781 | 0.0781 |
Trypanosoma brucei | unspecified product | 0.0036 | 0.4358 | 0.3879 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0781 | 0.0781 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0068 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Echinococcus granulosus | dna polymerase kappa | 0.0043 | 0.5538 | 0.5538 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Echinococcus multilocularis | dna polymerase eta | 0.0015 | 0.0781 | 0.0781 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.7443 | 0.7443 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0043 | 0.5538 | 0.516 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0068 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.4628 | 0.4628 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0036 | 0.4358 | 0.3879 |
Echinococcus multilocularis | dna polymerase kappa | 0.0043 | 0.5538 | 0.5538 |
Giardia lamblia | DINP protein human, muc B family | 0.0022 | 0.1961 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0032 | 0.3752 | 0.3223 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.3752 | 0.3752 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.4628 | 0.4172 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0043 | 0.5538 | 0.516 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0068 | 1 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0043 | 0.5538 | 0.5 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0068 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.4628 | 0.4628 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0015 | 0.0781 | 0.0781 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.004 | 0.5027 | 0.5027 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.